Psoriasis and TNF blockers

Why this ailment is now included on the warning label

Amplify’d from www.altmeds.com

Psoriasis among the TNF blocker risks

The US Food and Drug Administration (FDA) is requiring the manufacturers of TNF blockers to update the Boxed Warning in the prescribing information to alert healthcare professionals of an increased risk of lymphoma and other malignancies in children and adolescents who receive these drugs, as well as an increased risk of psoriasis. Read more at www.altmeds.com

 

See this Amp at http://amplify.com/u/a1ct8b